palmidrol has been researched along with l 663536 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Ascoli, F; Bari, M; Erba, F; Finazzi-Agrò, A; Fiorucci, L; Maccarrone, M | 1 |
Blackbeard, J; Hasnie, F; Lambert, DM; Pheby, T; Rice, AS; Segerdahl, AR; Vandevoorde, S; Wallace, VC | 1 |
Carratù, MR; Esposito, G; Scuderi, C; Steardo, L; Stecca, C; Valenza, M | 1 |
Capoccia, E; Cuomo, R; Esposito, G; Lu, J; Palumbo, I; Sarnelli, G; Steardo, A; Steardo, L; Turco, F | 1 |
5 other study(ies) available for palmidrol and l 663536
Article | Year |
---|---|
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Human mast cells take up and hydrolyze anandamide under the control of 5-lipoxygenase and do not express cannabinoid receptors.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Amides; Arachidonate 5-Lipoxygenase; Arachidonic Acids; Binding, Competitive; Biological Transport; Cannabinoids; Cell Line; Cyclooxygenase Inhibitors; Endocannabinoids; Ethanolamines; Humans; Ibuprofen; Indoles; Indomethacin; Kinetics; Lipoxygenase Inhibitors; Mast Cells; Palmitic Acids; Polyunsaturated Alkamides; Receptors, Cannabinoid; Receptors, Drug; Tritium | 2000 |
The effect of the palmitoylethanolamide analogue, palmitoylallylamide (L-29) on pain behaviour in rodent models of neuropathy.
Topics: Amides; Amines; Animals; Behavior, Animal; Camphanes; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Endocannabinoids; Ethanolamines; Gabapentin; gamma-Aminobutyric Acid; Hindlimb; Indoles; Injections, Intraperitoneal; Male; Pain; Pain Measurement; Pain Threshold; Palmitic Acids; Physical Stimulation; Piperidines; PPAR alpha; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Sciatic Neuropathy; Temperature; Zalcitabine | 2007 |
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α.
Topics: Amides; Amyloid beta-Peptides; Animals; Animals, Newborn; Apoptosis; Brain; Cell Proliferation; Cells, Cultured; Coculture Techniques; Embryo, Mammalian; Endocannabinoids; Enzyme Inhibitors; Ethanolamines; Glial Fibrillary Acidic Protein; Hippocampus; Indoles; Microtubule-Associated Proteins; Neuroglia; Neurons; Neuroprotective Agents; Organ Culture Techniques; Palmitic Acids; PPAR alpha; Rats; Rats, Sprague-Dawley | 2012 |
Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation.
Topics: Amides; Anilides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Colitis; Colitis, Ulcerative; Colon, Sigmoid; Cyclooxygenase 2; Dextran Sulfate; Dinoprostone; Endocannabinoids; Ethanolamines; Female; Glial Fibrillary Acidic Protein; Humans; Indoles; Male; Mice; Middle Aged; Nerve Tissue Proteins; Neuroglia; Neutrophil Infiltration; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Palmitic Acids; PPAR alpha; PPAR gamma; Rectum; S100 Calcium Binding Protein beta Subunit; Severity of Illness Index; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2014 |